RadNet (RDNT)
(Delayed Data from NSDQ)
$56.22 USD
-0.47 (-0.83%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $60.45 +4.23 (7.52%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
RadNet (RDNT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$58.00 | $63.00 | $48.00 | 2.31% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for RadNet comes to $58.00. The forecasts range from a low of $48.00 to a high of $63.00. The average price target represents an increase of 2.31% from the last closing price of $56.69.
Analyst Price Targets (4 )
Broker Rating
RadNet currently has an average brokerage recommendation (ABR) of 1.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.60 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 60% and 20% of all recommendations. A month ago, Strong Buy made up 60%, while Buy represented 20%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/RDNT.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.60 | 1.60 | 1.60 | 1.60 | 1.60 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/9/2024 | Raymond James | John W Ransom | Moderate Buy | Moderate Buy |
3/6/2024 | Not Identified | Not Identified | Not Available | Hold |
3/4/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
2/8/2024 | CJS Securities | Lawrence S Solow | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.60 |
ABR (Last week) | 1.60 |
# of Recs in ABR | 5 |
Average Target Price | $58.00 |
LT Growth Rate | NA |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 54 of 252 |
Current Quarter EPS Est: | 0.16 |